MIM Reports 23% Increase In Net Income For Fourth Quarter 2004; Specialty Revenues Increase 40% Merger Expected To Close By Mid-March

ELMSFORD, N.Y.--(BUSINESS WIRE)--Feb. 17, 2005--MIM Corporation (NASDAQ:MIMS) (CBOE:OQX) (PCX:OQX), a pharmaceutical healthcare organization, today reported fourth quarter and 2004 results.